Sloning Biotechnology has announced a distribution partnership with Research & Innovation Japan Inc. (RIJ).
RIJ will exclusively market and sell Sloning´s gene synthesis service (Slonomics™) and the product family of gene mutant libraries (Slonomax™) in Japan.
“We are very pleased that RIJ will join our global network of qualified distributors. Their technological strength and market awareness makes RIJ the ideal partner to co-develop the Japanese market.” stated Thomas Matthes, the company CBO.
Kiyohiko Hirasawa, founder and CEO of RIJ said “Sloning´s products and services perfectly addressing the current demand in genomics research and protein engineering. We are looking forward to represent Sloning in Japan”.